Publications

[Immune-Enhancing Effects of Limosilactobacillus fermentum in BALB/c Mice Immunosuppressed by Cyclophosphamide],  2023,  NUTRIENTS

[Characterization of a new CCCTC-binding factor binding site as a dual regulator of Epstein-Barr virus latent infection],  2023,  PLOS PATHOGENS

[Anti-Tumor Effect of Heat-Killed Bifidobacterium bifidum on Human Gastric Cancer through Akt-p53-Dependent Mitochondrial Apoptosis in Xenograft Models],  2022,  INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

[Apigenin Increases Natural Killer Cytotoxicity to Human Hepatocellular Carcinoma Expressing HIF-1 alpha through High Interaction of CD95/CD95L],  2022,  JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY

[Anti-Tumor Effects of Heat-Killed L. reuteri MG5346 and L. casei MG4584 against Human Colorectal Carcinoma through Caspase-9-Dependent Apoptosis in Xenograft Model],  2022,  MICROORGANISMS

[The antitumor effect of natural killer cells against hepatocellular carcinoma through CXCL9],  2022,  MOLECULAR & CELLULAR TOXICOLOGY

[The Inhibitory Effect of NLRP3 Deficiency in Hepatocellular Carcinoma SK-Hep1 Cells],  2021,  microbiology and biotechnology letters

[Korean Red Ginseng Enhances Immunotherapeutic Effects of NK Cells via Eosinophils in Metastatic Liver Cancer Model],  2021,  nutrients

[Postbiotics for cancer prevention and treatment],  2021,  Korean journal of microbiology

[NLRP3 Deficiency in Hepatocellular Carcinoma Enhances Surveillance of NK-92 through a Modulation of MICA/B],  2021,  International Journal of Molecular Sciences

[Cisplatin Resistance in Epstein–Barr-Virus-Associated Gastric Carcinoma Acquired through ATM Methylation],  2021,  CANCERS

[Natural killer cells inhibit breast cancer cell invasion through downregulation of urokinase type plasminogen activator],  2020,  ONCOLOGY REPORTS

[FoxP3, PD-1 and CTLA-4 are decreased significantly after a tenofovir therapy in patients with chronic hepatitis B],  2020,  Future Virology